RE:RE:RE:RE:RE:RE:RE:Incentives to have a 1st cohort (UHN) 3-month data publishskys1 wrote: Claridge, I agree with all you said. It is all well written and no doubt all true, but you have to admit that even though TLT's technology has made remarkable progress, everything else seems to drag on forever even according to their timelines. Take Ph 2 for example. First it was start early in 1st Q, then 1st Q, then early in 2nd Q, then by end of 2nd Q. We are now in 3rd Q and still nothing. How could they possible be so far off the mark so often? It has always been this way. Take the then CEO's prediction that they would apply for the NAS by June of 2016. That's a joke and a bad one at that. I will end by saying when you are trying to raise money you need a product with superior potential and substantial executive credibility. They have the former but the later has been greatly damaged by this nonsense, and leaves much to be desired. It is no wonder, and explains why they are still trying to raise money @ .30 US p/s even with their remarkable Ph 1 results.
Well said, both the former and current management really unqualified to match the brilliant technology, yet both management teams refused to admit. Just hope no more drag on phase 2 trial side.